A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
Rinaldi M, Crinò L, Scagliotti GV, Mosconi AM, De Marinis F, Gridelli C, Selvaggi G, Della Giulia M, Darwish S, Porrozzi S, Novello S, Cipri A, Bartolucci R, Calandri C, Tonato M.
Rinaldi M, et al. Among authors: gridelli c.
Ann Oncol. 2000 Oct;11(10):1295-300. doi: 10.1023/a:1008334610955.
Ann Oncol. 2000.
PMID: 11106119
Free article.
Clinical Trial.